报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 41.63% | 4.75% | 3.66% | 44/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
2024-06-30 | 40.16% | -6.69% | 5.58% | 45/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
2024-03-31 | 38.03% | -11.38% | -1.35% | 45/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
2023-12-31 | 38.55% | -10.88% | -2.99% | 44/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
2023-09-30 | 39.74% | 2% | -7.66% | 43/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
2023-06-30 | 43.04% | 3.71% | 0.28% | 40/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
2023-03-31 | 42.92% | 2% | -0.79% | 41/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
2022-12-31 | 43.26% | -6.86% | 4.24% | 41/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
2022-06-30 | 41.5% | -14.05% | -10.65% | 42/54 | 69.18% | 我武生物 | 95.63% | 行业排名> |
2021-12-31 | 46.44% | -0.81% | -3.81% | 42/54 | 72.33% | 我武生物 | 95.75% | 行业排名> |
2021-06-30 | 48.28% | 2% | 3.12% | 39/54 | 73.72% | 华兰疫苗 | 98.39% | 行业排名> |
2020-12-31 | 46.82% | 0.33% | 0.33% | 40/54 | 71.61% | 百奥泰 | 95.74% | 行业排名> |
2019-12-31 | 46.67% | 5.3% | 5.3% | 37/54 | 72.44% | 我武生物 | 95.89% | 行业排名> |
2018-12-31 | 44.32% | 2% | 2% | 34/54 | 71.54% | 百奥泰 | 96.33% | 行业排名> |